SEATS 2026

Your Content Goes Here

0

Days

0

Hours

0

Minutes

0

Seconds

Register Now

VIEW SCIENTIFIC PROGRAMME

VIEW WORKSHOPS

0

Days

0

Hours

0

Minutes

0

Seconds

Earn CME Points at SEATS X MLCC 2026

Make the most of your congress experience while earning Continuing Medical Education (CME) points!

CME points for local doctors will be awarded to delegates attending SEATS X MLCC 2026, based on your attendance duration:

SEATS 2026 (11 – 14 November 2026) | 4-Day Attendance
16 CME Points
SEATS X MLCC 2026 (11 –15 November 2026) | 5-Day Attendance
20 CME Points
MLCC 2026 (15 November 2026) | 1-Day Attendance
4 CME Points

Join us for an enriching congress experience combining clinical knowledge, scientific exchange and the latest advances in thoracic medicine.

We look forward to welcoming you to SEATS X MLCC 2026!

Welcome Message

Welcome to the 5th Annual Congress of the South East Asian Thoracic Society (SEATS 2026), held in conjunction with the 6th Multi-Disciplinary Lung Cancer Conference (MLCC 2026), taking place from 11 – 15 November 2026 at the Grand Hyatt Singapore.

This year marks an exciting milestone as SEATS 2026 (11 – 14 November) and MLCC 2026 (15 November) come together for the first time, bringing two leading scientific meetings under one roof. By co-locating the two conferences, we have created a unique platform that maximises value for our delegates, faculty, industry partners, and the wider healthcare community. Through aligned scientific programmes and schedules, participants will benefit from a distinguished international faculty, enhanced multidisciplinary collaboration, and a broader regional audience.

meet our faculty for SEATS 2026

Abbas E Abbas

Akif Turna

Atsushi Kamigaichi

Khader Hussain

Kim Hyun Koo

M. Odbaatar

Mariko Fukui

Yap Cheng Hon

VIEW FACULTY

Collaborating Societies

Platinum Sponsor

Gold Sponsors

Silver Sponsor

Bronze Sponsors

Exhibitors

Highlights of SEATS 2025

Sign up for our newsletter

SUBSCRIBE NOW

Get the latest updates of SEATS X MLCC 2026 straight to your inbox!

Time	09:00 – 16:00 (GMT+8)
Venue	Grand Hyatt Singapore, Residence 6, Level 3
Format	Rotating hands-on stations with focused short didactic sessions and practical demonstrations
Introduction	This hands-on workshop is designed to strengthen both the technical execution and clinical reasoning required for advanced bronchoscopy and interventional pulmonology. Each station combines short expert demonstrations with deliberate practice, troubleshooting, and discussion of indications, safety checks, and complication management
Objectives	– Develop a structured approach to procedure planning, including indication, airway anatomy, lesion or nodal target, device selection, and rescue strategy. – Improve hands-on familiarity with convex-probe EBUS bronchoscopes, R-EBUS probes, guide sheaths, biopsy tools, cryoprobes, ablative devices, rigid bronchoscopes, and airway stents. – Practice stepwise technical execution with attention to ergonomics, team communication, equipment readiness, and procedural flow. – Recognise pitfalls early and apply practical strategies for bleeding, airway obstruction, pneumothorax risk, device malposition, and loss of target access.
Target Participants	Respiratory physicians, interventional pulmonologists, thoracic surgeons, respiratory and thoracic fellows and trainees, intensivists with an interest in advanced bronchoscopy, bronchoscopy nurses, and allied healthcare professionals involved in bronchoscopy services.
Participants Number	30 pax
Lead Faculty	Eric D. Tenda Melvin Tay C.K. SS Kho
Faculty	Regional and international multidisciplinary experts in respiratory medicine and interventional pulmonology

Time	07:30 – 17:00 (GMT+8)
Venue	Grand Hyatt Singapore, Residence 5, Level 3
Format	Interactive, case-based multidisciplinary workshop focused on precision lung cancer care, integrating molecular tumour board discussions, real-world case simulations, and live audience polling.
Introduction	This workshop focuses on the practical application of molecular profiling in lung cancer, including NGS, liquid biopsy, and minimal residual disease (MRD). Emphasis is placed on translating biomarker data into real-world clinical decision-making across early-stage and advanced disease settings.
Objectives	– Apply NGS and molecular profiling in lung cancer management – Interpret ctDNA and MRD results in clinical practice – Integrate biomarker data into treatment decisions – Manage early and advanced NSCLC using precision oncology approaches – Conduct multidisciplinary tumour board (MTB)–style decision-making in clinical scenarios – Discuss real-world challenges in implementing molecular diagnostics in routine practice – Evaluate emerging roles of perioperative and adjuvant biomarker-guided therapies
Target Participants	Medical oncologists, thoracic surgeons, pulmonologists, pathologists, radiation oncologists, trainees, and allied health professionals.
Lead Faculty	Aaron Tan
Faculty	Regional and international multidisciplinary experts in thoracic oncology and molecular diagnostics.

American Samoa	Gibraltar	Panama
Andorra	Greece	Poland
Antigua and Barbuda	Greenland	Portugal
Aruba	Guam	Puerto Rico
Australia	Guyana	Qatar
Austria	Hong Kong SAR, China	Romania
Bahamas, The	Hungary	Russian Federation
Bahrain	Iceland	San Marino
Barbados	Ireland	Saudi Arabia
Belgium	Isle of Man	Seychelles
Bermuda	Israel	Singapore
British Virgin Islands	Italy	Sint Maarten (Dutch part)
Brunei Darussalam	Japan	Slovak Republic
Bulgaria	Korea, Rep.	Slovenia
Canada	Kuwait	Spain
Cayman Islands	Latvia	St. Kitts and Nevis
Channel Islands	Liechtenstein	St. Martin (French part)
Chile	Lithuania	Sweden
Costa Rica	Luxembourg	Switzerland
Croatia	Macao SAR, China	Taiwan, China
Curaçao	Malta	Trinidad and Tobago
Cyprus	Monaco	Turks and Caicos Islands
Czechia	Nauru	United Arab Emirates
Denmark	Netherlands	United Kingdom
Estonia	New Caledonia	United States
Faroe Islands	New Zealand	Uruguay
Finland	Northern Mariana Islands	Virgin Islands (U.S.)
France	Norway
French Polynesia	Oman
Germany	Palau

Afghanistan	Korea, Dem. People’s Rep	Somalia
Burkina Faso	Liberia	South Sudan
Burundi	Madagascar	Sudan
Central African Republic	Malawi	Syrian Arab Republic
Chad	Mali	Togo
Congo, Dem. Rep	Mozambique	Uganda
Eritrea	Niger	Yemen, Rep.
Gambia, The	Rwanda
Guinea-Bissau	Sierra Leone

Albania	Equatorial Guinea	Moldova
Algeria	Fiji	Mongolia
Argentina	Gabon	Montenegro
Armenia	Georgia	North Macedonia
Azerbaijan	Grenada	Paraguay
Belarus	Guatemala	Peru
Belize	Indonesia	Samoa
Bosnia and Herzegovina	Iran, Islamic Rep.	Serbia
Botswana	Iraq	South Africa
Brazil	Jamaica	St. Lucia
Cabo Verde	Kazakhstan	St. Vincent and the Grenadines
China	Kosovo	Suriname
Colombia	Libya	Thailand
Cuba	Malaysia	Tonga
Dominica	Maldives	Türkiye
Dominican Republic	Marshall Islands	Turkmenistan
Ecuador	Mauritius	Tuvalu
El Salvador	Mexico	Ukraine

Earn CME Points at SEATS X MLCC 2026

Welcome Message

meet our faculty for SEATS 2026

Collaborating Societies

Platinum Sponsor

Gold Sponsors

Silver Sponsor

Bronze Sponsors

Exhibitors

Highlights of SEATS 2025

Sign up for our newsletter

Organised by

Managed by

Supported by

Held in

Pulmonology Workshop

Oncology Workshop

High-Income Countries (HIC)

Low-Income Countries (LIC)

Upper Middle-Income Countries (UMIC)

Lower Middle-Income Countries (LMIC)

Security Notice

Angola	India	Papua New Guinea
Bangladesh	Jordan	Philippines
Benin	Kenya	São Tomé and Principe
Bhutan	Kiribati	Senegal
Bolivia	Kyrgyz Republic	Solomon Islands
Cambodia	Lao PDR	Sri Lanka
Cameroon	Lebanon	Tajikistan
Comoros	Lesotho	Tanzania
Congo, Rep.	Mauritania	Timor-Leste
Côte d’Ivoire	Micronesia, Fed. Sts.	Tunisia
Djibouti	Morocco	Uzbekistan
Egypt, Arab Rep.	Myanmar	Vanuatu
Eswatini	Namibia	Viet Nam
Ghana	Nepal	West Bank and Gaza
Guinea	Nicaragua	Zambia
Haiti	Nigeria	Zimbabwe
Honduras	Pakistan